Committed to sharing our science

Committed to sharing our science

327 results available

Update on FORTITUDE-ALS: a Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis

Poster, 29th International Symposium on ALS/MND
Glasgow, Scotland, UK
December 2018
Association Between Decline in Slow Vital Capacity and Respiratory Insufficiency, Use of Assisted Ventilation, Tracheostomy, or Death in Patients With Amyotrophic Lateral Sclerosis

JAMA Neurology
Andrews JA, Meng L, Kulke SF, Rudnicki SA, Wolff AA, Bozik ME, Malik FI, Shefner JM
January 2018
CK‐2127107 amplifies skeletal muscle response to nerve activation in humans

Muscle & Nerve
Andrews JA, Miller TM, Vijayakumar V, Stoltz R, James JK, Meng L, Wolff AA, Malik FI.
November 18, 2017
Comparison of slow and forced vital capacities on ability to predict survival in ALS

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Pinto S, de Carvalho M
October 2017
The Fast Skeletal Troponin Activator, CK-2127107, Improves Muscle Function in Mouse Models of Spinal Muscular Atrophy

Poster, 2017 MDA Scientific Conference
Arlington, VA
Hwee DT, DiDonato CJ, Malik FI, Chin ER
March 2017